Erratum: Intrauterine growth retardation and lack of teratogenic effects of prenatal exposure to the combination of paracetamol and caffeine in Wistar rats (Reproductive Toxicology (2003) 17 (51-58) DOI: 10.1016/S0890-6238(02)00097-7);Intrauterine growth retardation and lack of teratogenic effects of prenatal exposure to the combination of paracetamol and caffeine in Wistar rats

Reproductive Toxicology

Volumn 17, Issue 1, 2003, Pages 51-58

  Burdan, Franciszek ^a  

^a MEDICAL UNIVERSITY OF LUBLIN   (Poland)

Author keywords

Acetaminophen; Caffeine; COX; Cyclooxygenase inhibitor; Fetus; Intrauterine growth retardation; OTC; Paracetamol; Prenatal toxicity; Teratogenesis

Indexed keywords

CAFFEINE; PARACETAMOL;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONGENITAL MALFORMATION; CONTROLLED STUDY; DELIVERY; DISEASE ASSOCIATION; DOSE RESPONSE; FEMALE; FETUS WEIGHT; FOOD DRUG INTERACTION; GESTATIONAL AGE; INTRAUTERINE GROWTH RETARDATION; KIDNEY MASS; LAPAROTOMY; LIVER WEIGHT; MALE; NONHUMAN; PLACENTA WEIGHT; PREGNANCY; PRENATAL DEVELOPMENT; PRENATAL EXPOSURE; TERATOGENICITY; WEIGHT GAIN;

RATTUS NORVEGICUS;

EID: 0037219639     PISSN: 08906238     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.reprotox.2004.02.004     Document Type: Erratum

References (64)

1. McElhatton PR, Sullivan FM, Volans GN, Fitzpatric R. Paracetamol poisoning in pregnancy: an analysis of the outcomes of cases referred to the Teratology Information Service of the national poisons Information Service. Hum Exp Toxicol 1990;9:147-53.
2. Prescott LF. Paracetamol (acetaminophen). A critical bibliographic review. London: Taylor & Francis; 1996.
3. McElhatton PR, Sullivan FM, Volans GN. Paracetamol overdose in pregnancy. Analysis of the outcome of 300 cases referred to the Teratology Information Service. Reprod Toxicol 1997;11:85-94.
4. Briggs GG, Freeman RK, Yaffe SJ. Drugs in pregnancy and lactation: a reference guide to fetal and neonatal risk. 5th ed. Baltimore: Williams & Wilkins; 1998, p. 4-8, 125-31.
5. Burdan F. Prenatal-toxicity of paracetamol. Pol Merkuriusz Lek 1999;7:289-91.
6. Prescott LF. Paracetamol: past, present, and future. Am J Ther 2000;7:143-7.
7. Patel P. Toxicity of over-the-counter stimulants. JAMA 1984;252:1898-903.
8. Narod SA, de Sanjose S, Victora C. Coffee during pregnancy: a reproductive hazard? Am J Obstet Gynecol 1991;164:1109-14.
9. Infante-Rivard C, Fernandez A, Gauthier R, David M, Rivard GE. Fetal loss associated with caffeine intake before and during pregnancy. JAMA 1993;270:2940-3.
10. Burdan F. Teratogenicity and embryotoxicity of caffeine: facts and hypothesis. Pol Merkuriusz Lek 2000;9:726-8.
11. Christian MS, Brent RL. Teratogen update: evaluation of the reproductive and developmental risk of caffeine. Teratology 2001;64:51-78.
12. Wojcik J, Samochowiec L, Laczynski L, et al. A double-blind comparative evaluation of aspirin, paracetamol and paracetamol + caffeine (Finimal) for their analgesic effectiveness. Arch Immun Ther Exp 1977;25:175-9.
13. Laska E, Sunschine A, Zighelboim I, Roure C, Morrero I, Wanderling J, et al. Effect of caffeine on acetaminophen analgesia. Clin Pharm Ther 1983;109:10-1.
14. Laska E, Sunschine A, Mueller F, Elvers WB, Slegel C, Rubin A. Caffeine as an analgesic adjuvant. JAMA 1984;251:1711-8.
15. Reynolds J, editor. Martindale. The extra pharmacopoeia. London: Royal Pharmaceutical Society; 1996.
16. Arky R, editor. Physicians' desk reference. Montvale: Medical Economics Company; 2002.
17. Burdan F, Wyskiel M. Embryotoxic effect of low doses of caffeine. Ann Univ Mariae Curie Sklodowska [Med] 1999;54:69-73.
18. Burdan F, Madej B, Wojtowicz Z, Maciejewski R, Radzikowska E. The effects of short-time caffeine administration on skeleton development in Wistar rats. Folia Morphol 2000;59:91-5.
19. Burdan F. Evaluation of bone formation in fetal skeletons following prenatal paracetamol administration in single alizarin-stained specimens in Wistar rats. Folia Morphol 2000;59:167-71.
20. Burdan F, Siezieniewska Z, Kis G, Blicharski T. Embryofetotxicity of acetaminophen in in-vivo experimental model. Ann Univ Mariae Curie Sklodowska [Med] 2001;56:89-95.
21. Manson JM, Kang YJ. Test methods for assessing female reproductive and development toxicology. In: Hayes AW, editor. Principles and methods of toxicology. 3rd ed. New York: Raven Press; 1994, p. 989-1038.
22. U.S. Food and Drug Administration. Good laboratory practice regulations for nonclinical laboratory studies. Code of Federal Regulations (CFR) March 21, 1994:56FR1200.
23. American National Research Council. Guide for the care and use of laboratory animals. Washington, DC: National Academy Press; 1996.
24. Gorska P. Principles in laboratory animal research for experimental purpose. Med Sci Monit 2000;6:171-80.
25. Faqi AS, Schweinfurth H, Chahoud I. Developmental toxicity of an octyltin stabilizer in NMRI mice. Reprod Toxicol 2001;15:117-22.
26. Danneman PJ, Mandrell TD. Evaluation of five agents/methods for anesthesia of neonatal rodents. Lab Anim Sci 1997;47:386-95.
27. Young AD, Phipps DE, Astroff B. Large-scale double-stained of rat fetal skeletons using alizarin red-S and alcian blue. Teratology 2000;61:273-6.
28. Burdan E. Formation of the knee joint after prenatal propyphenazone (isopropylantipyrine) administration. Cells Tissues Organs 2002;171:145-51.
29. Chahoud I, Faqi AS. Atlas of external and skeletal anomalies in rats (CD-ROM). Berlin: Pr&C MULTIMEDIA; 1997.
30. Chahoud I, Buschmann J, Clark R, et al. Classification terms in developmental toxicology: need for harmonisation. Reprod Toxicol 1999;13:77-82.
31. Wise DL, Beck SL, Beltrame D, et al. Terminology of developmental abnormalities in common laboratory mammals [version 1]. Teratology 1997;55:249-92.
32. Solecki R, Burgin H, Buschmann J. Harmonisation of rat fetal skeletal terminology and classification. Report of the third workshop on the terminology in developmental toxicology. Reprod Toxicol 2001;15:713-21.
33. Gad SC, Weil CS. Statistics for toxicologist. In: Hayes AW, editor. Principles and methods of toxicology. 3rd ed. New York: Raven Press; 1994, p. 221-74.
34. Shein-Chung C, Jen-Pein L, editors. Design and analysis of animal studies in pharmaceutical development. New York: Marcel Dekker; 1998.
35. Scott Jr WJ. Caffeine-induced limb malformations: description of malformations and quantitation of placental transfer. Teratology 1983;28:427-35.
36. Collins TFX, Welsh JJ, Black TN, Whitby KE, O'Donnell Jr MW. Potential reversibility of skeletal effects in rats exposed in utero to caffeine. Food Chem Toxic 1987;25:647-62.
37. Mutter TF. Caffeine and reduction of fetal ossification in the rat: fact or artifact? Teratology 1988;37:239-47.
38. Wyskiel M. Influence of acetylsalicylic acid and paracetamol on embryonal and fetal Wistar rat development - Ph.D. Thesis. Lublin: Medical University of Lublin; 1998.
39. Nishimura H, Nakai K. Congenital malformation in offspring of mice treated with caffeine. Proc Soc Exp Biol 1960;104:140-2.
40. Skalko RG, Poche PD, Kwasigroch TE. The toxicology of chemical interactions during pregnancy in the mouse: caffeine and phenytoin. Toxicology 1984;30:7-16.
41. York RG, Randall JL, Scott Jr WJ. Reduction of caffeine teratogenicity in mice by inducing maternal drug metabolism with β-naphthoflavone. Teratology 1985;31:217-25.
42. Elamzar MMA, McElhatton PR, Sullivan FM. Studies on the teratogenic effects of different oral preparations of caffeine in mice. Toxicology 1982;23:57-71.
43. Aeschbacher HU, Milon H, Poot A, Wurzner HP. Effect of caffeine on rat offspring from treated darns. Toxicol Lett 1980;7:71-7.
44. Nolen GA. The effect of brewed and instant coffee on reproduction and teratogenesis in the rats. Toxicol Appl Pharmacol 1981;58:171-83.
45. Nolen GA. A reproduction/teratology study of brewed and instant decaffeinated coffees. J Toxicol Environ Health 1982;10:769-82.
46. Lubawy WC, Burriss-Garret RJ. Effect of aspirin and acetaminophen on fetal and placental grow in rats. J Pharm Sci 1977;66:111-3.
47. Reel J, Lawton AD, Lamb JC. Reproductive toxicity evaluation of acetaminophen in Swiss CD-1 mice using a continuous breeding protocol. Fundam Appl Toxicol 1992;18:233-9.
48. Momma K, Takao A. Transplacental cardiovascular effects of four popular analgesics in rats. Am J Obstet Gynecol 1990;162:1304-10.
49. Burdan F, Siezieniewska Z, Urbanowicz Z. Combined effects of acetaminophen, isopropylantipyrine and caffeine on pregnant and nonpregnant liver. Hum Exp Toxicol 2001;20:569-75.
50. Burdan F. Effects of prenatal exposure to combination of acetaminophen, isopropylantipyrine and caffeine on intrauterine development in rats. Hum Exp Toxicol 2002;21:25-31.
51. Chahoud I, Ligensa A, Dietzel L, Faqi AS. Correlation between maternal toxicity and embryo/fetal effects. Reprod Toxicol 1999;13:375-81.
52. McNail JR. The possible teratogenic effect of salicylates on the developing fetus. Brief summary of eight suggestive cases. Clin Pediatr 1978;12:347-50.
53. Skalko RG, Newton MP, Niles AM. The effect of 5-bromodeoxyuridine on mouse limb development: a scanning electron microscope study. Acta Embryol Exp 1977;3:323-33.
54. Fujii T, Nakatsuka T. Potentiating effects of caffeine on teratogenicity of alkylating agents in mice. Teratology 1983;28:29-33.
55. Vogel R, Spielmann H. Potentiating effect of caffeine on embryotoxicity of cyclophosphamide treatment in vivo during the preimplantation period. Teratog Carcinog Mutagen 1987;7:169-74.
56. Ritter EJ, Scott WJ, Wilson JG, Mathinos PR, Randall JL. Potentiative interactions between caffeine and various teratogenic agents. Teratology 1982;25:95-100.
57. Ritter EJ, Scott Jr WJ, Randall JL, Ritter JM. Teratogenicity of di(2-ethylhexyl)phthalate, 2-ethylhexanol, 2-ethylhexanoic acid and valproic acid and potentiation by caffeine. Teratology 1987;35:41-6.
58. Beck SL, Urbano CM. Potentiating effect of caffeine on teratogenicity of acetazolamide in C57BL/6J mice. Teratology 1991;44:241-50.
59. Beck SL, Urbano CM. Acetazolamide with caffeine causes exencephaly in "resistant" SWV mice. Reprod Toxicol 1993;7:123-9.
60. Yielding LW, Riley TL, Yielding KL. Preliminary study of caffeine and chloroquine enhancement of x-ray induced birth defects. Biochem Biophys Res Commun 1976;68:1356-61.
61. Clark RL, Eschbach K, Cusick WA, Heyse JF. Interactions between caffeine and adenosine antagonists in producing embryo resorptions and malformations in mice. Toxicol Appl Pharmacol 1987;91:371-85.
62. Nash JE, Persaud TVN. Influence of nicotine and caffeine on rat embryonic development. Histol Histopathol 1988;3:377-88.
63. Fadel RAR, Persaud TVN. Effects of alcohol and caffeine on cultured whole rat embryos. Acta Anat 1992;144:114-9.
64. Aselton P, Jick H, Milunsky A, Hunte JR, Stergachis A. First trimester drug use and congenital disorders. Obstet Gynecol 1985;65:451-5.